Abivax SA (ABVX)
86.99
-0.02
(-0.02%)
USD |
NASDAQ |
Oct 08, 11:12
Abivax Net Income (Quarterly) : -136.54M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -136.54M |
| March 31, 2026 | -56.70M |
| December 31, 2025 | -95.40M |
| Date | Value |
|---|---|
| September 30, 2025 | -179.22M |
| June 30, 2025 | -54.88M |
| March 31, 2025 | -55.12M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Poxel SA | -- |
| OSE Immunotherapeutics SA | -- |
| Cogent Biosciences, Inc. | -96.40M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 136.54M |
| EPS Diluted (Quarterly) | -1.714 |
| Enterprise Value | 6.486B |
| Earnings Yield | -7.02% |
| Normalized Earnings Yield | -5.780 |